Release Date: May 02, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Q: Can you quantify the impact of tariffs on DexKo's EBITDA and how competitors are affected? A: Adrian Letts, Managing Partner, Private Equity: Performance in Q1 was in line with expectations, with some recovery signs in North America. The business has managed costs well, improving margins despite a down market. Tariffs will impact competitors, but DexKo is well-positioned to manage through this.
Q: What is the status of Clarios' 45X tax filing and any policy changes affecting it? A: Jaspreet Dehl, CFO: There is no change in our views on the tax credit. Clarios filed its 2024 tax return in January, and it's being processed normally. We expect to receive the tax benefits from the 2024 return soon.
Q: Could you elaborate on plans to return capital to shareholders, possibly through a larger share buyback program? A: Anuj Ranjan, CEO: We continuously look for monetization opportunities. We've returned $10 billion over two years, and we have options for further monetizations. We plan to renew our buyback program in August, balancing deleveraging, returning capital, and new investments.
Q: Can you provide more context on the realignment at Scientific Games and its value enhancement? A: Adrian Letts, Managing Partner, Private Equity: We're investing in digital, aiming to digitize the $100 billion lottery ecosystem. We've deployed innovative technologies and appointed a new Head of Digital to accelerate growth, which we believe will significantly enhance EBITDA.
Q: Will BBU participate in the Barclays payments business investment, and what is the investment pipeline in the payment sector? A: Anuj Ranjan, CEO: Yes, BBU will participate. Barclays aligns with our strategy in financial infrastructure, where we see opportunities to transform businesses. We've successfully done this with Magneti and Network, and we plan to apply similar strategies with Barclays.
Q: What is the status of Schoeller Allibert's merger with IPL, and does it provide an exit for Brookfield and BBU? A: Adrian Letts, Managing Partner, Private Equity: The merger creates a sustainable packaging producer at scale. The transaction doesn't require additional funding from BBU, and we expect it to close in Q3. It presents a significant value creation opportunity.
Q: How is customer churn at CDK, and what are the impacts on business performance? A: Jaspreet Dehl, CFO: Year-over-year performance is lower due to technology investments. Churn is higher among single-product customers, but stabilizing among core DMS customers. Commercial actions and contract extensions are mitigating churn impacts.
Q: Can you update us on Unidas' performance and any macro impacts? A: Jaspreet Dehl, CFO: Unidas is performing well, with stable fleet management contracts and ongoing transformation activities. While interest rates in Brazil impact costs, the business remains free cash flow positive, and we're optimistic about its long-term prospects.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
This article first appeared on GuruFocus.Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.